HIGHLIGHTS
- who: Anne-Els van de Logt from the Radboud University(INSERM), UMR-S1155, Paris, France have published the Article: Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy, in the Journal: (JOURNAL)
- what: The authors evaluated the value of baseline anti-phospholipase A2 receptor (PLA2R1) antibody titer as a prognostic biomarker in patients with PLA2R1-associated membranous nephropathy. To discuss management strategies with the individual patient, the authors provide the test characteristics of aPLA2R1ab for the prediction of progression (Supplementary Appendix Part B Table S4a). The endpoint in this study, doubling of serum creatinine, or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.